Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women. / Shahrbabaki, Sobhan Salari; Linz, Dominik; Hartmann, Simon; Redline, Susan; Baumert, Mathias.
In: European Heart Journal, Vol. 42, No. 21, 2021, p. 2088-2099.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women
AU - Shahrbabaki, Sobhan Salari
AU - Linz, Dominik
AU - Hartmann, Simon
AU - Redline, Susan
AU - Baumert, Mathias
PY - 2021
Y1 - 2021
N2 - Aims: To quantify the arousal burden (AB) across large cohort studies and determine its association with long-term cardiovascular (CV) and overall mortality in men and women.Methods and results: We measured the AB on overnight polysomnograms of 2782 men in the Osteoporotic Fractures in Men Study (MrOS) Sleep study, 424 women in the Study of Osteoporotic Fractures (SOF) and 2221 men and 2574 women in the Sleep Heart Health Study (SHHS). During 11.2 +/- 2.1 years of follow-up in MrOS, 665 men died, including 236 CV deaths. During 6.4 +/- 1.6 years of follow-up in SOF, 105 women died, including 47 CV deaths. During 10.7 +/- 3.1 years of follow-up in SHHS, 987 participants died, including 344 CV deaths. In women, multivariable Cox proportional hazard analysis adjusted for common confounders demonstrated that AB is associated with all-cause mortality [SOF: hazard ratio (HR) 1.58 (1.01-2.42), P = 0.038; SHHS-women: HR 1.21 (1.06-1.42), P = 0.012] and CV mortality [SOF: HR 2.17 (1.04-4.50), P = 0.037; SHHS-women: HR 1.60 (1.12-2.28), P = 0.009]. In men, the association between AB and all-cause mortality [MrOS: HR 1.11 (0.94-1.32), P = 0.261; SHHS-men: HR 1.31 (1.06-1.62), P = 0.011] and CV mortality [MrOS: HR 1.35 (1.02-1.79), P = 0.034; SHHS-men: HR 1.24 (0.86-1.79), P = 0.271] was less clear.Conclusions: Nocturnal AB is associated with long-term CV and all-cause mortality in women and to a lesser extent in men.[GRAPHICS]
AB - Aims: To quantify the arousal burden (AB) across large cohort studies and determine its association with long-term cardiovascular (CV) and overall mortality in men and women.Methods and results: We measured the AB on overnight polysomnograms of 2782 men in the Osteoporotic Fractures in Men Study (MrOS) Sleep study, 424 women in the Study of Osteoporotic Fractures (SOF) and 2221 men and 2574 women in the Sleep Heart Health Study (SHHS). During 11.2 +/- 2.1 years of follow-up in MrOS, 665 men died, including 236 CV deaths. During 6.4 +/- 1.6 years of follow-up in SOF, 105 women died, including 47 CV deaths. During 10.7 +/- 3.1 years of follow-up in SHHS, 987 participants died, including 344 CV deaths. In women, multivariable Cox proportional hazard analysis adjusted for common confounders demonstrated that AB is associated with all-cause mortality [SOF: hazard ratio (HR) 1.58 (1.01-2.42), P = 0.038; SHHS-women: HR 1.21 (1.06-1.42), P = 0.012] and CV mortality [SOF: HR 2.17 (1.04-4.50), P = 0.037; SHHS-women: HR 1.60 (1.12-2.28), P = 0.009]. In men, the association between AB and all-cause mortality [MrOS: HR 1.11 (0.94-1.32), P = 0.261; SHHS-men: HR 1.31 (1.06-1.62), P = 0.011] and CV mortality [MrOS: HR 1.35 (1.02-1.79), P = 0.034; SHHS-men: HR 1.24 (0.86-1.79), P = 0.271] was less clear.Conclusions: Nocturnal AB is associated with long-term CV and all-cause mortality in women and to a lesser extent in men.[GRAPHICS]
KW - Sleep
KW - Arousal
KW - Sleep fragmentation
KW - Total sleep time
KW - Cohort study
KW - Cardiovascular mortality
KW - All-cause mortality
KW - RISK-FACTOR
KW - DURATION
KW - FRAGMENTATION
KW - APNEA
U2 - 10.1093/eurheartj/ehab151
DO - 10.1093/eurheartj/ehab151
M3 - Journal article
C2 - 33876221
VL - 42
SP - 2088
EP - 2099
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 21
ER -
ID: 274612891